AXA lessened its stake in Colgate-Palmolive (NYSE:CL) by 1.6% during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 819,698 shares of the company’s stock after selling 13,603 shares during the quarter. AXA owned approximately 0.09% of Colgate-Palmolive worth $59,715,000 as of its most recent filing with the SEC.
Several other institutional investors also recently modified their holdings of the company. Jacobi Capital Management LLC raised its stake in Colgate-Palmolive by 125.5% during the third quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock worth $104,000 after acquiring an additional 803 shares during the period. Krilogy Financial LLC increased its stake in shares of Colgate-Palmolive by 23.0% in the second quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock valued at $115,000 after purchasing an additional 289 shares during the period. Captrust Financial Advisors acquired a new stake in shares of Colgate-Palmolive in the second quarter valued at approximately $122,000. AlphaMark Advisors LLC increased its stake in shares of Colgate-Palmolive by 1.5% in the second quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock valued at $126,000 after purchasing an additional 25 shares during the period. Finally, Bruderman Asset Management LLC acquired a new stake in shares of Colgate-Palmolive in the second quarter valued at approximately $126,000. Institutional investors and hedge funds own 72.85% of the company’s stock.
In related news, insider Jennifer Daniels sold 7,375 shares of the firm’s stock in a transaction that occurred on Wednesday, December 13th. The shares were sold at an average price of $73.18, for a total value of $539,702.50. Following the completion of the transaction, the insider now owns 38,691 shares of the company’s stock, valued at approximately $2,831,407.38. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Henning I. Jakobsen sold 36,215 shares of the firm’s stock in a transaction that occurred on Monday, February 5th. The stock was sold at an average price of $71.22, for a total transaction of $2,579,232.30. Following the completion of the transaction, the vice president now directly owns 70,783 shares of the company’s stock, valued at approximately $5,041,165.26. The disclosure for this sale can be found here. Insiders have sold 414,019 shares of company stock valued at $29,541,377 over the last 90 days. 1.02% of the stock is currently owned by insiders.
Shares of Colgate-Palmolive (NYSE CL) traded down $0.68 during trading hours on Wednesday, reaching $69.62. 3,579,222 shares of the company were exchanged, compared to its average volume of 4,417,115. The company has a market capitalization of $61,460.00, a PE ratio of 30.54, a price-to-earnings-growth ratio of 2.60 and a beta of 0.75. Colgate-Palmolive has a 1 year low of $67.52 and a 1 year high of $77.91. The company has a quick ratio of 0.34, a current ratio of 0.47 and a debt-to-equity ratio of 24.42.
Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, January 26th. The company reported $0.75 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.75. The firm had revenue of $3.89 billion during the quarter, compared to analysts’ expectations of $3.92 billion. Colgate-Palmolive had a net margin of 13.10% and a return on equity of 1,716.69%. The firm’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period last year, the firm posted $0.75 earnings per share. research analysts predict that Colgate-Palmolive will post 3.18 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, February 15th. Investors of record on Tuesday, January 23rd will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 2.30%. The ex-dividend date of this dividend is Monday, January 22nd. Colgate-Palmolive’s payout ratio is 70.18%.
Several equities research analysts have commented on CL shares. Citigroup dropped their price target on shares of Colgate-Palmolive from $76.00 to $75.00 and set a “neutral” rating on the stock in a research note on Thursday, November 2nd. Zacks Investment Research upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $81.00 price target on the stock in a research note on Monday, October 23rd. KeyCorp restated a “hold” rating on shares of Colgate-Palmolive in a research note on Saturday, November 25th. Macquarie upgraded shares of Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 price target on the stock in a research note on Tuesday, December 19th. Finally, Deutsche Bank initiated coverage on shares of Colgate-Palmolive in a research note on Wednesday, December 13th. They issued a “hold” rating and a $75.00 price target on the stock. Three investment analysts have rated the stock with a sell rating, eleven have given a hold rating and five have given a buy rating to the company. Colgate-Palmolive presently has an average rating of “Hold” and an average price target of $77.71.
COPYRIGHT VIOLATION NOTICE: “Axa Sells 13,603 Shares of Colgate-Palmolive (NYSE:CL)” was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece of content on another site, it was stolen and republished in violation of international copyright and trademark law. The legal version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/02/14/axa-sells-13603-shares-of-colgate-palmolive-cl-3.html.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.